Search

Search Results
Results 7331 - 7340 of 8357 for allergy
  • Drug - 29 Apr 2021
    Consumer Medicine Information (CMI) about Reminyl (Galantamine hydrobromide) intended for persons living in Australia.
  • Drug - 23 Apr 2021
    Consumer Medicine Information (CMI) about Pamisol (disodium pamidronate) intended for persons living in Australia.
  • News - 6 Apr 2021
    For sports fans across the country, the resumption of the regular sports calendar has signaled another step toward post-pandemic normality. But for the athletes participating in professional,...
  • Drug - 30 Mar 2021
    Consumer Medicine Information (CMI) about DBL Heparin Sodium (Heparin Sodium) intended for persons living in Australia.
  • Drug - 11 Mar 2021
    Consumer Medicine Information (CMI) about Atectura Breezhaler (Indacaterol / mometasone furoate) intended for persons living in Australia.
  • News - 2 Mar 2021
    Researchers at Imperial College London in the UK have reported on round five of the REal-time Assessment of Community Transmission-2 (REACT-2) program – a cross-sectional community survey measuring...
  • News - 24 Feb 2021
    News-Medical talks to Parry Hashemi about research on in vivo probes for detecting inflammation markers in humans and animals she will present at Pittcon.
  • Drug - 19 Feb 2021
    Consumer Medicine Information (CMI) about Besponsa (Inotuzumab ozogamicin) intended for persons living in Australia.
  • Drug - 17 Feb 2021
    Consumer Medicine Information (CMI) about Volibris (Ambrisentan) intended for persons living in Australia.
  • News - 3 Feb 2021
    April 30 will mark the end of the first 100 days of President Joe Biden's tenure. That's a benchmark presidents often set for making good on high-priority campaign promises.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.